Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV
Status:
Completed
Trial end date:
2020-11-06
Target enrollment:
Participant gender:
Summary
This is a multicentre, phase IV, randomised, open-label, trial exploring adjunctive maraviroc
and/or metformin for liver steatosis over 48 weeks.
Sponsored by University College London Coordinated by MRC Clinical Trials Unit at UCL
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
MRC [ycm] University College, London
Collaborators:
Medical Research Council Royal Free Hospital NHS Foundation Trust ViiV Healthcare